Whose mark got the ‘X’ Factor? Relaxo Footwear vs XS Brands
The Delhi High Court dismissed Relaxo Footwear’s claim over the 'X' device mark against XS Brands, highlighting the significance of coexistence and lack of confusion in trademark disputes.…
811 articles
The Delhi High Court dismissed Relaxo Footwear’s claim over the 'X' device mark against XS Brands, highlighting the significance of coexistence and lack of confusion in trademark disputes.…
The Indian IP Office has scheduled the Patent and Trademark Agent Examinations for January 2025. This announcement details eligibility, exam format, and inclusivity measures, inviting aspiring professionals including…
The Madras High Court granted MRF a permanent injunction and nominal damages against Powermax for trademark and copyright infringement. The judgment underscores the legal significance of safeguarding established…
The Calcutta High Court set aside a trademark refusal for Electronica India due to lack of reasoning and significant procedural lapses, instructing the registry to provide a fresh…
The Bombay High Court has restrained Gleck Pharma from using XIGAMET for its diabetes product, finding it deceptively similar to Glenmark’s ZITA-MET. This decision highlights the Court’s heightened…
The Delhi High Court enforced an injunction against BETNEVIN, holding it infringed Glaxo's BETNESOL trademark. The Court clarified that infringement can be determined in execution proceedings to enforce…
The Delhi High Court has ordered the removal of the CROCKSCLUB trademark after finding it deceptively similar to the registered CROCS mark. The judgment highlights the need for…
The Calcutta High Court examined Emami’s claims against Unilever over the use of "Handsome" in skincare branding. While trademark infringement was not established, the Court found grounds for…
The Madras High Court remanded a trademark dispute involving Prem Biyani and Zee Entertainment, focusing on class distinctions and the status of well-known marks. The judgment highlights the…
The Bombay High Court restored Indi Pharma’s VOMISET trademark, permitting late renewal due to non-receipt of statutory notice. The order clarifies rights under Section 25(3) of the Trade…